降钙素原在慢性阻塞性肺疾病急性加重期的临床应用研究

The Clinical Application Value of Calcitonin on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的:观察降钙素原在慢性阻塞性肺疾病急性加重期的应用价值。方法:将2013年1月-2014年6月在英德市人民医院住院治疗的42例慢性阻塞性肺疾病急性加重期患者分为观察组和对照组,均为21例,对比治疗效果。结果:两组患者抗生素应用、二重感染、平均住院时间、平均抗生素使用时间和平均住院费用相比,差异具有统计学意义(P<0.05)。结论:降钙素原可规范抗生素使用,判定慢性阻塞性肺疾病急性加重期患者的病情,缩短患者使用抗菌药物时间。

Objective To observe the application value of procalcitonin reduced acute exacerbation of chronic obstructive pulmonary disease. Methods 42 cases of chronic obstructive pulmonary disease in acute exacerbation period were divided into treatment group and control group, 21 cases in each one. The treatment effect were compared between two groups. Results The use of antibiotics, double infection, the average hospital stay, average duration of antibiotic use and average hospitalization costs had signifi cant, P0.05. Conclusion Procalcitonin can regulate the use of antibiotics, the determination condition of patients with acute exacerbation of chronic obstructive pulmonary disease to short the dosage of antibacterial drugs.